IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER
Clinical trials for IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER explained in plain language.
Never miss a new study
Get alerted when new IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER trials appear
Sign up with your email to follow new studies for IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for families: new pill targets autism irritability in kids
Symptom relief Not yet recruitingThis study tests whether a new medication, KarXT plus KarX-EC, can reduce irritability in children and teens (ages 5 to 17) with autism. About 176 participants will receive either the drug or a placebo for 8 weeks. The main goal is to see if the drug improves irritability scores …
Matched conditions: IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC
-
Hope for autism irritability: new drug trial for kids
Symptom relief Not yet recruitingThis study tests a new medicine (KarXT + KarX-EC) to see if it can reduce irritability in children and teens with autism. About 176 participants aged 5 to 17 will receive either the drug or a placebo. The main goal is to check if the drug improves behavior and is safe to use.
Matched conditions: IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC